Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

210.34
Delayed Data
As of May 05
 -4.28 / -1.99%
Today’s Change
209.77
Today|||52-Week Range
340.34
-32.69%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Operating ActivitiesNet Income / Starting Line98.3M-749.7M-1.6B3.9B
 
 
 
 
 
Depreciation578.6M1.0B2.8B5.6B
 
 
 
 
 
Total Other Cash Flow246.1M1.4B2.2B3.7B
 
 
 
 
 
Funds From Operations702.0M1.4B2.7B5.8B
 
 
 
 
 
Funds From/For Other Operating Expenses36.2M163.6M431.9M1.3B
 
 
 
 
 
Net Cash Flow - Operating Activities665.8M1.2B2.2B4.5B
 
 
 
 
 
 
InvestingIncrease In Investments-5.2M0.00-1.0M-24.3M
 
 
 
 
Decrease In Investments58.9M33.2M12.0M883.0M
 
 
 
 
 
Capital Expenditures-137.5M-177.9M-238.6M-454.9M
 
 
 
 
 
Fixed Asset Disposal8.0M11.6M13.7M140.1M
 
 
 
 
 
Net Assets From Acquisitions -5.7B-15.1M-5.6B-37.5B
 
 
 
 
 
Other Investing - Uses-156.7M0.000.000.00
 
 
Other Investing - Sources235.3M2.9M441.7M--
 
 
 
 
Net Cash Flow Investing-5.7B-275.3M-5.4B-37.1B
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings6.0B2.4B9.1B29.8B
 
 
 
 
 
Long Term Debt Reduction-679.7M-3.2B-6.1B-5.1B
 
 
 
 
 
Net Proceeds Stock Sale18.8M48.0M105.9M9.2B
 
 
 
 
 
Common Preferred Redeemed-16.1M-170.0M-130.1M-118.0M
 
 
 
 
 
Common Dividends0.000.000.00-208.1M
 
 
Cash Dividends Paid - Total0.000.000.00-208.1M
 
 
Other Sources - Financing13.7M69.0M51.1M76.1M
 
 
 
 
 
Other Uses - Financing109.8M14.7M14.3M230.1M
 
 
 
 
 
Net Cash Flow - Financing5.2B-867.3M3.0B33.4B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash3.3M-60.9M-5.9M-6.5M
 
 
 
 
 
 
Net Change In Cash106.4M70.9M-110.1M852.5M